Pharmaceutical
Industry Pakistan
Breaking news, DRAP updates, industry insights, company announcements & regulatory developments
National drug regulatory body ensuring safety, efficacy and quality of pharmaceutical products.
Peak industry body representing over 500 pharmaceutical manufacturers across Pakistan.
Regulatory body governing pharmacy education, practice and professional standards.
National medical association promoting healthcare standards and ethical medical practice.
Government initiative promoting pharmaceutical exports and international market access.
Premier health research institution overseeing vaccine production and public health initiatives.
Featured News
Pharma News
China Competition, ‘Destruction’ at FDA Offers Chance for Restructuring, Says Rick Pazdur
Former FDA top oncology regulator Rick Pazdur discusses the agency’s recent political appointees and suggests a chance for fundamental restructuring amid growing Chinese drug
Pharma News
Pharmaceutical Industry Sees Key Appointments and Promotions with GC Therapeutics Hiring Stefan Irion as Chief Scientific Officer
Latest pharmaceutical industry appointments and promotions, including GC Therapeutics hiring Stefan Irion as chief scientific officer, formerly of BlueRock Therapeutics, and other
Pharma News
FDA Acting Commissioner Receives Praise Amidst Ongoing Political Developments in Washington
The FDA's acting commissioner has been praised, while Republicans face challenges in passing an immigration funding bill that may have indirect implications for healthcare
Have a Pharmaceutical Story or Press Release?
Share your company news, research findings, or industry insights with thousands of pharma professionals reading The Herald Today.
Latest Pharma News
Pharmalittle: We’re Reading About a Lilly Gene Therapy for Cholesterol, Three New Lilly Deals, and More
Eli Lilly's gene therapy shows promise in reducing cholesterol levels, while the company secures new vaccine developers to expand its infectious disease portfolio.
Five Biotech News Updates to Stay On Top of Today
Stay informed on key biotech developments including Eli Lilly’s gene-editing progress, AI drug discovery insights, and new FDA leadership.
Eli Lilly Acquires Three Small Vaccine Developers for Up to $4 Billion
Eli Lilly expands its vaccine portfolio by acquiring Curevo, LimmaTech Biologics, and Vaccine Company in a deal that could cost up to nearly $4 billion.
Pierre Fabre Laboratories Secures CHMP Approval for First-Line BRAFTOVI Regimen in BRAFV600E-Mutant Metastatic Colorectal Cancer
Pierre Fabre Laboratories has secured CHMP approval for the first-line BRAFTOVI regimen, showing a significant survival benefit in patients with BRAFV600E-mutant metastatic
Resolution Therapeutics Celebrates Positive 4-Year MATCH Data in Liver Cirrhosis, Bolsters Case for EMERALD Trial
Resolution Therapeutics highlights promising 4-year MATCH study results, reinforcing the potential of their engineered macrophage therapy RTX001 for treating liver cirrhosis.
Pharmaceutical Companies Exploit Patent System to Extend Monopoly Control Over Life Saving Drugs Like Humira
Pharmaceutical companies are using the patent system to extend their monopoly control over life-saving drugs, limiting access to affordable medications and hindering innovation in
How Kyle Diamantas Defied Expectations to Rise as FDA’s Top Food Official
Discover how little-known Florida attorney Kyle Diamantas overcame skepticism and rose to lead the FDA's food safety division amid turbulent times.
Eli Lilly's Gene-Editing Therapy Reduces Cholesterol Levels by 62% in Early Study
Eli Lilly reports significant cholesterol reduction with Verve’s gene editor, raising hopes for a one-time treatment to combat heart disease.
Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial
Eli Lilly reports its obesity drug retatrutide led to near-bariatric surgery weight loss, but with high side effect rates prompting questions about its appeal.
EU and US Advisers Clash on AstraZeneca Breast Cancer Drug Approval
EU and US advisers are divided over approval of AstraZeneca's breast cancer drug. Details here.The European Medicines Agency (EMA) and the U.S.
Survey Highlights Persistent Uncertainty on STI Vaccines
While data from the Centers for Disease Control and Prevention (CDC) indicate that the total number of U.S.
Genentech Solicits Research on Pharma Reforms for Grants
Earlier this month, Genentech, a leading pharmaceutical company, offered numerous academics and researchers the opportunity to receive up to $125,000 in grants to produce papers that align with key
The hantavirus outbreak is the warning the world needs to improve pandemic preparedness
The latest case of a Canadian passenger testing positive for hantavirus underscores the ongoing nature of this outbreak.
Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more
STAT+: Latest updates on Eli Lilly's obesity drug trial and statistical issues with amyloid-targeting Alzheimer's treatments. Stay informed.Good morning, everyone, and how are you today?
Immunovant Shares Surge on Arthritis Trial Data
STAT Immunovant shares have surged following positive data from an arthritis trial.
Supreme Court Rejects Pharma Lawsuits, TrumpRx Expands Drug Savings Programs
Top of the morning to you, and a fine one it is. We can tell because the sun is shining and cool breezes are blowing by the Pharmalot campus, although they may dissipate as temperatures start
Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more
STAT's Andrew Joseph discusses biotech investor sentiment, political risks, and FDA optimism with David Kessler at Breakthrough Summit West.Hey there, and happy Wednesday.
Stay Updated with Pakistan Pharmaceutical Industry
Follow us for daily updates on DRAP regulations, PPMA announcements, company news, and industry analysis.